KINCL, Vladimír, Roman PANOVSKÝ, Tomáš KEPÁK, Viera BAJČIOVÁ, Veronika BEDNÁROVÁ, Lukáš OPATŘIL and Jan MÁCHAL. Assessment of late cardiotoxic effects in patients treated for cancer in childhood. Cancer Medicine. HOBOKEN: John Wiley & Sons Ltd., 2022, vol. 11, No 8, p. 1763-1768. ISSN 2045-7634. Available from: https://dx.doi.org/10.1002/cam4.4564.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Assessment of late cardiotoxic effects in patients treated for cancer in childhood
Authors KINCL, Vladimír (203 Czech Republic, guarantor, belonging to the institution), Roman PANOVSKÝ (203 Czech Republic, belonging to the institution), Tomáš KEPÁK (203 Czech Republic, belonging to the institution), Viera BAJČIOVÁ (703 Slovakia, belonging to the institution), Veronika BEDNÁROVÁ (703 Slovakia, belonging to the institution), Lukáš OPATŘIL (203 Czech Republic, belonging to the institution) and Jan MÁCHAL (203 Czech Republic, belonging to the institution).
Edition Cancer Medicine, HOBOKEN, John Wiley & Sons Ltd. 2022, 2045-7634.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.000
RIV identification code RIV/00216224:14110/22:00128258
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/cam4.4564
UT WoS 000761794900001
Keywords in English late cardiotoxic effects; cancer in childhood
Tags 14110115, 14110321, 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/1/2023 09:24.
Abstract
Background: The most frequent chemotherapeutic regimens used in children's cancer contain anthracyclines, which may have potentially cardiotoxic effects even at a later point in time. Echocardiography including tissue Doppler imaging is well-proved noninvasive method to assess cardiac function. Objectives: To assess the late cardiotoxic effects in young adults treated for various cancer types in childhood. Methods: Ninety-eight young adults who were treated for childhood cancer (CCS), median time 12.1 years after finishing the therapy, were comprised into study. All subjects underwent echocardiographic examination including tissue Doppler imaging. The echocardiographic parameters were compared to 57 healthy age-matched subjects. The CCS group also underwent 24-h ECG Holter monitoring to reveal any arrhythmias. Results: The subjects in CCS group had lower E' velocities from lateral (15.6 vs. 17.6 cm/s) and septal part (12.2 vs. 14.4 cm/s) of mitral annulus (p for both <0.001) and also lower S' velocity from the tricuspid annulus (12.4. vs. 13.3 cm/s, p = 0.013) and tricuspid annulus peak systolic excursion (TAPSE; 22.2 vs. 23.9 mm, p = 0.017). There were no significant differences in left ventricular systolic velocities or ejection fraction. The occurrence of arrhythmias did not differ among subgroups of CCS with or without anthracycline therapy. Conclusion: Childhood cancer survivors had subclinical cardiac impairment in comparison with healthy controls, particularly in left ventricular diastolic function.
Links
MUNI/A/1685/2020, interní kód MUName: Nové trendy v diagnostice a terapii kardiomyopatií
Investor: Masaryk University
PrintDisplayed: 24/6/2024 20:02